LGALS3 and B-cell chronic lymphocytic leukemia: On the contrary, the non-responding group had significantly higher Gal-3 plasma levels (Figure 9A) and Gal-3 mRNA expression (Figure 9C) in CLL cells compared to the patients with CR/PR.